A |
2025-03-17 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
25132.0000 |
209472.0000 |
1 |
0000898437 |
Common Stock |
D |
2025-03-17 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
12152.0000 |
197320.0000 |
2 |
0000898437 |
Common Stock |
D |
2025-03-17 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
25132.0000 |
50263.0000 |
6 |
0000898437 |
Restricted Stock Unit |
A |
2025-03-14 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
73559.0000 |
73559.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2025-03-14 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
71403.0000 |
71403.0000 |
5 |
0000898437 |
Restricted Stock Unit |
A |
2025-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30060.0000 |
197015.0000 |
1 |
0000898437 |
Common Stock |
D |
2025-03-11 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
12675.0000 |
184340.0000 |
2 |
0000898437 |
Common Stock |
D |
2025-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30060.0000 |
0.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2025-03-10 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
20002.0000 |
172826.0000 |
1 |
0000898437 |
Common Stock |
D |
2025-03-10 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
5871.0000 |
166955.0000 |
2 |
0000898437 |
Common Stock |
D |
2025-03-10 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
20002.0000 |
20001.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2024-06-05 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
18068.0000 |
18068.0000 |
1 |
0001827087 |
Stock Option Award (Right to Buy) |
D |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
D-Return |
--D |
5017.0000 |
0.0000 |
1 |
0001827087 |
Stock Option Award (Right to Buy) |
A |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
5017.0000 |
5017.0000 |
2 |
0001827087 |
Stock Option Award (Right to Buy) |
D |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
D-Return |
--D |
12155.0000 |
0.0000 |
3 |
0001827087 |
Stock Option Award (Right to Buy) |
A |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
12155.0000 |
12155.0000 |
4 |
0001827087 |
Stock Option Award (Right to Buy) |
D |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
D-Return |
--D |
6432.0000 |
0.0000 |
5 |
0001827087 |
Stock Option Award (Right to Buy) |
A |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
6432.0000 |
6432.0000 |
6 |
0001827087 |
Stock Option Award (Right to Buy) |
D |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
D-Return |
--D |
13928.0000 |
0.0000 |
7 |
0001827087 |
Stock Option Award (Right to Buy) |
A |
2024-05-03 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
13928.0000 |
13928.0000 |
8 |
0001827087 |
Stock Option Award (Right to Buy) |
A |
2024-03-15 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
75395.0000 |
75395.0000 |
1 |
0000898437 |
Restricted Stock Unit |
A |
2024-03-15 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
182699.0000 |
182699.0000 |
2 |
0000898437 |
Stock Option (Right to Buy) |
A |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14420.0000 |
129614.0000 |
1 |
0000898437 |
Common Stock |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
6973.0000 |
122641.0000 |
2 |
0000898437 |
Common Stock |
A |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
20001.0000 |
142642.0000 |
3 |
0000898437 |
Common Stock |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
6473.0000 |
136169.0000 |
4 |
0000898437 |
Common Stock |
A |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30059.0000 |
166228.0000 |
5 |
0000898437 |
Common Stock |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
14534.0000 |
151694.0000 |
6 |
0000898437 |
Common Stock |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14420.0000 |
0.0000 |
8 |
0000898437 |
Restricted Stock Unit |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
20001.0000 |
40003.0000 |
9 |
0000898437 |
Restricted Stock Unit |
D |
2024-03-11 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30059.0000 |
30060.0000 |
10 |
0000898437 |
Restricted Stock Unit |
A |
2024-03-01 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
24761.0000 |
24761.0000 |
1 |
0001827087 |
Stock Option Grant (Right to Buy) |
A |
2023-06-21 |
|
Dare Bioscience, Inc. |
4 |
A-Award |
--D |
40000.0000 |
40000.0000 |
1 |
0001401914 |
Stock Option (right to buy) |
A |
2023-06-07 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
13928.0000 |
13928.0000 |
1 |
0001827087 |
Stock Option Grant (Right to Buy) |
A |
2023-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24575.0000 |
125155.0000 |
1 |
0000898437 |
Common Stock |
D |
2023-04-26 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
10900.0000 |
114255.0000 |
2 |
0000898437 |
Common Stock |
D |
2023-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24575.0000 |
0.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2023-03-10 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30060.0000 |
113791.0000 |
1 |
0000898437 |
Common Stock |
D |
2023-03-10 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
13211.0000 |
100580.0000 |
2 |
0000898437 |
Common Stock |
D |
2023-03-10 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
30060.0000 |
60119.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2023-03-09 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14419.0000 |
87963.0000 |
1 |
0000898437 |
Common Stock |
D |
2023-03-09 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
4232.0000 |
83731.0000 |
2 |
0000898437 |
Common Stock |
A |
2023-03-09 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
60004.0000 |
60004.0000 |
4 |
0000898437 |
Restricted Stock Unit |
A |
2023-03-09 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
130998.0000 |
130998.0000 |
5 |
0000898437 |
Stock Option (Right to Buy) |
D |
2023-03-09 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14419.0000 |
14420.0000 |
6 |
0000898437 |
Restricted Stock Unit |
A |
2023-03-01 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
6432.0000 |
6432.0000 |
1 |
0001827087 |
Stock Option Grant (Right to Buy) |
A |
2022-06-23 |
|
Dare Bioscience, Inc. |
4 |
A-Award |
--D |
38000.0000 |
38000.0000 |
1 |
0001401914 |
Stock Option (right to buy) |
A |
2022-06-09 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
12155.0000 |
12155.0000 |
1 |
0001827087 |
Stock Option Grant (Right to Buy) |
A |
2022-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24576.0000 |
72826.0000 |
1 |
0000898437 |
Common Stock |
D |
2022-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24576.0000 |
24575.0000 |
3 |
0000898437 |
Restricted Stock Unit |
A |
2022-03-11 |
|
Anika Therapeutics, Inc. |
4 |
P-Purchase |
--D |
4287.0000 |
56179.0000 |
1 |
0000898437 |
Common Stock |
A |
2022-03-11 |
|
Anika Therapeutics, Inc. |
4 |
P-Purchase |
--D |
3813.0000 |
59992.0000 |
2 |
0000898437 |
Common Stock |
A |
2022-03-11 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
90179.0000 |
90179.0000 |
1 |
0000898437 |
Restricted Stock Unit |
A |
2022-03-11 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
208821.0000 |
208821.0000 |
2 |
0000898437 |
Stock Option (Right to Buy) |
A |
2022-03-09 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14420.0000 |
51892.0000 |
1 |
0000898437 |
Common Stock |
D |
2022-03-09 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
14420.0000 |
28839.0000 |
2 |
0000898437 |
Restricted Stock Unit |
A |
2022-03-01 |
|
Vigil Neuroscience, Inc. |
4 |
A-Award |
--D |
5017.0000 |
5017.0000 |
1 |
0001827087 |
Stock Option Grant (Right to Buy) |
A |
2021-06-24 |
|
Dare Bioscience, Inc. |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0001401914 |
Stock Option (right to buy) |
A |
2021-06-15 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
2994.0000 |
37472.0000 |
1 |
0000898437 |
Common Stock |
D |
2021-06-15 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
2994.0000 |
101644.0000 |
2 |
0000898437 |
Stock Option (Right to Buy) |
A |
2021-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24575.0000 |
34478.0000 |
1 |
0000898437 |
Common Stock |
D |
2021-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
24575.0000 |
49151.0000 |
2 |
0000898437 |
Restricted Stock Unit |
A |
2021-03-09 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
43259.0000 |
43259.0000 |
1 |
0000898437 |
Restricted Stock Unit |
A |
2021-03-09 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
108398.0000 |
108398.0000 |
2 |
0000898437 |
Stock Option (Right to Buy) |
A |
2020-06-25 |
|
Dare Bioscience, Inc. |
4 |
A-Award |
--D |
22500.0000 |
22500.0000 |
1 |
0001401914 |
Stock Option (right to buy) |
A |
2020-05-26 |
|
Neuronetics, Inc. |
4 |
A-Award |
--D |
30000.0000 |
34437.0000 |
1 |
0001227636 |
Common Stock |
A |
2020-04-26 |
|
Anika Therapeutics, Inc. |
4 |
M-Exempt |
--D |
4231.0000 |
11697.0000 |
1 |
0000898437 |
Common Stock |
D |
2020-04-26 |
|
Anika Therapeutics, Inc. |
4 |
F-InKind |
--D |
1794.0000 |
9903.0000 |
2 |
0000898437 |
Common Stock |
A |
2020-04-26 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
73726.0000 |
73726.0000 |
3 |
0000898437 |
Restricted Stock Unit |
A |
2020-04-26 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
104638.0000 |
104638.0000 |
4 |
0000898437 |
Stock Option (Right to Buy) |
A |
2020-02-25 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
4231.0000 |
4231.0000 |
1 |
0000898437 |
Restricted Stock Unit |
A |
2019-11-20 |
|
Dare Bioscience, Inc. |
4 |
A-Award |
--D |
45000.0000 |
45000.0000 |
1 |
0001401914 |
Stock Option (right to buy) |
A |
2019-05-28 |
|
Neuronetics, Inc. |
4 |
A-Award |
--D |
3723.0000 |
4437.0000 |
1 |
0001227636 |
Common Stock |
A |
2019-05-28 |
|
Neuronetics, Inc. |
4 |
A-Award |
--D |
7347.0000 |
7347.0000 |
2 |
0001227636 |
Stock Option (right to buy) |
A |
2019-02-26 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
3842.0000 |
7466.0000 |
1 |
0000898437 |
Common Stock |
A |
2019-02-13 |
|
Neuronetics, Inc. |
4 |
A-Award |
--D |
714.0000 |
714.0000 |
1 |
0001227636 |
Common Stock |
A |
2019-02-13 |
|
Neuronetics, Inc. |
4 |
A-Award |
--D |
1453.0000 |
1453.0000 |
2 |
0001227636 |
Stock Option (right to buy) |
A |
2018-08-31 |
|
Anika Therapeutics, Inc. |
4 |
A-Award |
--D |
3624.0000 |
3624.0000 |
1 |
0000898437 |
Common Stock |
A |
2018-05-30 |
|
SeaSpine Holdings Corp |
4 |
A-Award |
--D |
8857.0000 |
28948.0000 |
1 |
0001637761 |
Common Stock |
A |
2017-06-14 |
|
SeaSpine Holdings Corp |
4 |
A-Award |
--D |
10081.0000 |
20091.0000 |
1 |
0001637761 |
Common Stock |